Anesthetic Efficacy of %4Alexadricaine Versus %2 Mepicaine-L in Children

NCT04477317 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2023-03-14

No results posted yet for this study

Summary

The aim of the present study is to evaluate and compare the anesthetic efficacy of Alexadricaine versus Mepecaine-L infiltration anesthesia in children during extraction of badly decayed or unrestorable maxillary first primary molars.

Conditions

  • Local Anesthesia

Interventions

DRUG

4% Articaine Hydrochloride with 1:100,000 Adrenaline

new Egyptian articane anesthetic solution.

DRUG

2% Mepivacaine Hydrochloride with 1:20,000 Levonordefrin

Mepecaine-L is the brand name of the Egyptian 2% Mepivacaine. It is the most commonly used anesthetic solution in Egypt due to its availability and its lower cost.

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Sara A mahmoud, Assoc. Prof. · Cairo University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
5 Years
Max Age
7 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-08-01
Primary Completion
2021-09-30
Completion
2021-10-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04477317 on ClinicalTrials.gov